Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

News in brief

man smoking synthetic drugs

Healthcare professionals can report adverse effects of legal highs through new website

28 MAR 2017

UK regulators have launched a pilot of a Yellow Card-type scheme for reporting adverse effects associated with legal highs and other illicit drugs.

US FDA building and signage

FDA speeds up approval for rare cancer drug

28 MAR 2017

Regulators in the United States have approved immunotherapy drug avelumab (Bavencio; Pfizer and Merck KGaA) for the treatment of a rare aggressive skin cancer under an accelerated evaluation process.

European Medicines Agency building, Canary Wharf

EMA calls for suspension of generic drugs after concerns about quality of data

28 MAR 2017

A list of generic drugs — including 41 that are available in the UK — have been recommended for suspension across the EU because of doubts over the quality of the bioequivalence data used to grant their national marketing authorisation. 

Vaughan Gething, health secretary in Wales

Reforms to Individual Patient Funding Request system in Wales approved

22 MAR 2017

Patients in Wales will no longer have to prove they have “exceptional clinical circumstances” in order to access drugs that are not routinely available on the NHS.

The Royal The Courts of Justice in London, which house the High Court and Court of Appeal of England and Wales

High Court told community pharmacy cuts introduced without 'basic fairness'

21 MAR 2017

The impact of the government slashing more than £320m from the community pharmacy budget in England was spelt out to a High Court judge on 21 March 2017 as the legal challenge to the cuts began.

Dilip Nathwani (left) current president British Society of Antimicrobial Chemotherapy and Philip Howard, president-elect

British Society of Antimicrobial Chemotherapy appoints first pharmacist president

20 MAR 2017

The British Society of Antimicrobial Chemotherapy (BSAC) has, for the first time in its 45-year history, appointed a pharmacist to be its president.

Sue Sharpe, chief executive of the PSNC

PSNC and NPA prepare to challenge government in court over community pharmacy funding decisions

20 MAR 2017

The legal challenges to the government’s decision to cut the community pharmacy budget in England — first announced in December 2015 — are due to begin in the High Court on 21 March 2017.

kings college, university of london

Nottingham, King's and UCL ranked among best in the world for pharmacy and pharmacology education

20 MAR 2017

Three UK universities that offer the Master of Pharmacy degree have been ranked among the best in the world for their pharmacy and pharmacology education.

severe atopic dermatitis

Dupilumab gets early access nod from UK regulator for atopic dermatitis

17 MAR 2017

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a positive opinion for dupilumab in atopic dermatitis under the Early Access to Medicines Scheme.

Ian Crompton, head of healthcare banking services at Lloyds Bank Commercial Banking Group

Business confidence among pharmacists hits rock bottom, Lloyds bank index reveals

17 MAR 2017

Business confidence among community pharmacists in England has fallen to a record low, according to the results of the annual Lloyds Bank Commercial Banking Healthcare Confidence Index.

DrugAge website screenshot

Database of anti-ageing compounds launched

17 MAR 2017

A database of anti-ageing compounds has been created by scientists at the University of Liverpool and the Biogerontology Research Foundation.

Adrenaline auto-injector

UK prescriptions for adrenaline auto-injectors soar in children

17 MAR 2017

The number of adrenaline auto-injectors provided in the UK for children has risen dramatically since 2000, but researchers say the reasons are often unclear. 

NHS walk-in sexual health centre, Liverpool city centre

Financial pressures are harming community-based NHS services, King's Fund report says

15 MAR 2017

Financial pressures on the NHS are harming community-based services, while some acute services are being shielded from cuts, putting the NHS ‘Five year forward view’ at risk, according to an analysis by The King’s Fund.

European Medicines Agency building, Canary Wharf

European Medicines Agency announces first public hearing to gather evidence for valproate safety review

15 MAR 2017

Members of the public are being invited to speak about their experiences of an epilepsy drug as part of a safety review by the European Medicines Agency (EMA).

Effects of NSAIDs on the heart

Combining NSAIDs with misoprostol may reduce risk of cardiovascular side effects

13 MAR 2017

Patients taking non-steroidal anti-inflammatory drugs (NSAIDs) and misoprostol, a drug commonly used to prevent and treat stomach ulcers, have a lower risk of having a serious cardiovascular event compared with patients taking NSAIDs alone, according to new research.

mobile-phone-app

App launched to help pharmacy undergraduates to learn about drugs

13 MAR 2017

A new app to support UK pharmacy undergraduates to learn about key drugs has been developed by a collaboration of 16 pharmacy schools.

Administering chemotherapy to patient

Nurses who administer cancer drugs could be at risk of developing health problems

13 MAR 2017

More research is needed to assess the harmful effects on oncology healthcare staff of administering cytotoxic drugs and whether enough is being done to protect them, a research report by consumer and business analyst MindMetre says.

NICE-office

NICE wants patients with suspected sepsis to be treated within an hour

10 MAR 2017

Patients with suspected sepsis must be assessed and treated within one hour by hospital staff if they are deemed to be at high risk of severe illness or death, the National Institute for Health and Care Excellence, the health technology assessment body, has said.

US Food and Drug Administration building

FDA approves desmopressin nasal spray for nocturnal polyuria

9 MAR 2017

The Food and Drug Administration has approved the first drug to be made available in the United States for nocturnal polyuria, a condition that can cause patients to wake frequently in the night to urinate.

General Pharmaceutical Council signage

Pharmacy regulator appoints financial services expert as deputy chief executive

9 MAR 2017

The General Pharmaceutical Council (GPhC) has appointed Megan Forbes as its deputy chief executive and director of operations, effective from 5 June 2017.

All News In Brief

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.